Leinonen M - Search Results

1

Evidence for infectious agents in cardiovascular disease and atherosclerosis.

Leinonen M, Saikku P. Leinonen M, et al. Lancet Infect Dis. 2002 Jan;2(1):11-7. doi: 10.1016/s1473-3099(01)00168-2. Lancet Infect Dis. 2002. PMID: 11892489 Review.

2

Chlamydial LPS and high-sensitivity CRP levels in serum are associated with an elevated body mass index in patients with cardiovascular disease.

Lajunen T, Vikatmaa P, Bloigu A, Ikonen T, Lepäntalo M, Pussinen PJ, Saikku P, Leinonen M. Lajunen T, et al. Among authors: leinonen m. Innate Immun. 2008 Dec;14(6):375-82. doi: 10.1177/1753425908099172. Innate Immun. 2008. PMID: 19039061 Free article.

3

Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.

Törmäkangas L, Erkkilä L, Korhonen T, Tiirola T, Bloigu A, Saikku P, Leinonen M. Törmäkangas L, et al. Among authors: leinonen m. Infect Immun. 2005 Oct;73(10):6458-66. doi: 10.1128/IAI.73.10.6458-6466.2005. Infect Immun. 2005. PMID: 16177317 Free PMC article.

4

The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland.

Kauppinen MT, Herva E, Kujala P, Leinonen M, Saikku P, Syrjälä H. Kauppinen MT, et al. Among authors: leinonen m. J Infect Dis. 1995 Nov;172(5):1330-5. doi: 10.1093/infdis/172.5.1330. J Infect Dis. 1995. PMID: 7594672

5

Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis.

Laurila A, Bloigu A, Näyhä S, Hassi J, Leinonen M, Saikku P. Laurila A, et al. Among authors: leinonen m. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2910-3. doi: 10.1161/01.atv.17.11.2910. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409275

6

IgG subclass-specific antibodies in Chlamydia pneumoniae infections.

Anttila T, Leinonen M, Surcel HM, Von Hertzen L, Bloigu A, Seppälä I, Saikku P. Anttila T, et al. Among authors: leinonen m. Scand J Infect Dis. 1998;30(4):381-6. doi: 10.1080/00365549850160684. Scand J Infect Dis. 1998. PMID: 9817519

7

Animal models for Chlamydia pneumoniae infection.

Saikku P, Laitinen K, Leinonen M. Saikku P, et al. Among authors: leinonen m. Atherosclerosis. 1998 Oct;140 Suppl 1:S17-9. doi: 10.1016/s0021-9150(98)00115-4. Atherosclerosis. 1998. PMID: 9859920 Review.

8

Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis.

Leinonen M, Saikku P. Leinonen M, et al. Am Heart J. 1999 Nov;138(5 Pt 2):S504-6. doi: 10.1016/s0002-8703(99)70286-3. Am Heart J. 1999. PMID: 10539859

9

Infections and atherosclerosis.

Leinonen M, Saikku P. Leinonen M, et al. Scand Cardiovasc J. 2000;34(1):12-20. doi: 10.1080/14017430050142341. Scand Cardiovasc J. 2000. PMID: 10816055 Free article. Review.

10

Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue.

Erkkilä L, Laitinen K, Laurila A, Saikku P, Leinonen M. Erkkilä L, et al. Among authors: leinonen m. Vaccine. 2002 May 22;20(17-18):2318-24. doi: 10.1016/s0264-410x(02)00098-1. Vaccine. 2002. PMID: 12009287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

491 results

Search Page

Filters